Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief: Maves at USP, Toll at Pharmavite, Lacik heads Reckitt North America

This article was originally published in The Tan Sheet

Executive Summary

Maves is USP’s development SVP; Pharmavite takes on Toll as sales exec; Lacik shifts to head Reckitt North America; Rainbow Light adds marketing and sales VPs; Lelinski heads Walgreens health and wellness; more People In Brief.

You may also be interested in...



Industry News Roundup

Sipes directs CDER Regulatory Policy; non-HFC propellant in Dr. Smith’s sprays; Bayer prioritizes health care investment; EMA oversight switch criticized; marketing, development changes At GNC; Pharmavite hires Kellogg, NBTY execs; and ‘Turtle Power’ for Colgate Kids Mouthwash.

Industry News Roundup

Sipes directs CDER Regulatory Policy; non-HFC propellant in Dr. Smith’s sprays; Bayer prioritizes health care investment; EMA oversight switch criticized; marketing, development changes At GNC; Pharmavite hires Kellogg, NBTY execs; and ‘Turtle Power’ for Colgate Kids Mouthwash.

CHPA Has Experienced Senior VP Corps To Cover In Maves Transition

The Consumer Healthcare Products Association has a senior staff cadre with almost 100 years of experience to run the OTC/dietary supplement trade association during the search for a new director in the wake of the departure of Michael Maves, MD

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106565

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel